Teva Pharmaceutical Industries Ltd
Close on Oct 19, 2026Market cap $48.13BP/E 68.9Yield –
Teva Pharmaceutical Industries GAAP Net Cash Provided by / Operating Activities
GAAP Net Cash Provided by / (Used in) Operating Activities ($M)
Teva Pharmaceutical Industries GAAP Net Cash Provided by / Operating Activities: $241M in Q3 2026, down 34.7% from a year earlier.
Where the Q3 2026 figure comes from
Source: SEC Form 10-Q (0000818686-26-000006) ↗
Reported in Database (financial_values) & SEC Form 10-Q / 10-K.
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up GAAP Net Cash Provided by / Operating Activities
- GAAP Share-Based Compensation Expense38 · Q3 2026
- GAAP Depreciation Expense (Total)–
- GAAP Net Gain / (Loss) on Sale of Long-Lived Assets & Divestitures69 · Q3 2026
- GAAP Net Cash Provided by / (Used in) Investing Activities210 · Q3 2026
- GAAP Purchases of Property, Plant and Equipment (Capital Expenditures)-120 · Q3 2026
- GAAP Net Cash Provided by / (Used in) Financing Activities6 · Q3 2026
- Proceeds from Exercise of Options and Employee Share Plans46 · Q3 2026
- Effect of Exchange Rate Changes on Cash and Cash Equivalents-27 · Q3 2026
- Net Change in Cash, Cash Equivalents and Restricted Cash430 · Q3 2026
- Cash, Cash Equivalents and Restricted Cash at Period-End4,085 · Q3 2026
Cite this data
StockData. (2026). Teva Pharmaceutical Industries GAAP Net Cash Provided by / Operating Activities ($M), quarterly Q1 2016–Q3 2026 [Data set]. Compiled from Teva Pharmaceutical Industries SEC filings and investor materials. https://stockdatahq.com/stocks/teva/kpis/db-cf-ocf
See every metric in the Teva Pharmaceutical Industries KPI table. Data updated Nov 10, 2026.
See a number that looks wrong?